Literature DB >> 23572237

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

Lauren B Krupp1, Marc Tardieu, Maria Pia Amato, Brenda Banwell, Tanuja Chitnis, Russell C Dale, Angelo Ghezzi, Rogier Hintzen, Andrew Kornberg, Daniela Pohl, Kevin Rostasy, Silvia Tenembaum, Evangeline Wassmer.   

Abstract

BACKGROUND: There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope.
OBJECTIVE: The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders.
METHODS: Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey.
RESULTS: Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey.
CONCLUSIONS: These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research.

Entities:  

Keywords:  Multiple sclerosis; acute disseminated encephalomyelitis; childhood multiple sclerosis; clinically isolated syndrome; neuromyelitis optica; pediatric multiple sclerosis

Mesh:

Year:  2013        PMID: 23572237     DOI: 10.1177/1352458513484547

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  193 in total

1.  MOG antibody-related disorders: common features and uncommon presentations.

Authors:  Álvaro Cobo-Calvo; Anne Ruiz; Hyacintha D'Indy; Anne-Lise Poulat; Maryline Carneiro; Nicolas Philippe; Françoise Durand-Dubief; Kumaran Deiva; Sandra Vukusic; Vincent Desportes; Romain Marignier
Journal:  J Neurol       Date:  2017-08-02       Impact factor: 4.849

2.  Functional-structural correlations in the afferent visual pathway in pediatric demyelination.

Authors:  E Ann Yeh; Ruth Ann Marrie; Y Arun Reginald; J Raymond Buncic; Austin E Noguera; Julia O'Mahony; Jean K Mah; Brenda Banwell; Fiona Costello
Journal:  Neurology       Date:  2014-10-31       Impact factor: 9.910

Review 3.  Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Authors:  Sniya Valsa Sudhakar; Karthik Muthusamy; Sunithi Mani; Sridhar Gibikote; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

4.  T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.

Authors:  Cather M Cala; Carson E Moseley; Chad Steele; Sarah M Dowdy; Gary R Cutter; Jayne M Ness; Tara M DeSilva
Journal:  J Neuroimmunol       Date:  2016-04-30       Impact factor: 3.478

5.  Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis.

Authors:  Leena Suleiman; Emmanuelle Waubant; Gregory Aaen; Anita Belman; Leslie Benson; Meghan Candee; Tanuja Chitnis; Mark Gorman; Manu Goyal; Benjamin Greenberg; Yolanda Harris; Janace Hart; Ilana Kahn; Lauren Krupp; Timothy Lotze; Soe Mar; Manikum Moodley; Jayne Ness; Bardia Nourbakhsh; Mary Rensel; Moses Rodriguez; John Rose; Jennifer Rubin; Teri Schreiner; Jan-Mendelt Tillema; Amy Waldman; Bianca Weinstock-Guttman; T Charles Casper; Michael Waltz; Jennifer S Graves
Journal:  Mult Scler Relat Disord       Date:  2018-03-26       Impact factor: 4.339

6.  Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Authors:  Yael Hacohen; Yu Yi Wong; Christian Lechner; Maciej Jurynczyk; Sukhvir Wright; Bahadir Konuskan; Judith Kalser; Anne Lise Poulat; Helene Maurey; Esther Ganelin-Cohen; Evangeline Wassmer; Chery Hemingway; Rob Forsyth; Eva Maria Hennes; M Isabel Leite; Olga Ciccarelli; Banu Anlar; Rogier Hintzen; Romain Marignier; Jacqueline Palace; Matthias Baumann; Kevin Rostásy; Rinze Neuteboom; Kumaran Deiva; Ming Lim
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

7.  Clinical and MRI phenotype of children with MOG antibodies.

Authors:  Cristina Fernandez-Carbonell; David Vargas-Lowy; Alexander Musallam; Brian Healy; Katherine McLaughlin; Kai W Wucherpfennig; Tanuja Chitnis
Journal:  Mult Scler       Date:  2015-06-03       Impact factor: 6.312

8.  Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis.

Authors:  Jennifer S Graves; Tanuja Chitnis; Bianca Weinstock-Guttman; Jennifer Rubin; Aaron S Zelikovitch; Bardia Nourbakhsh; Timothy Simmons; Michael Waltz; T Charles Casper; Emmanuelle Waubant
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

9.  Anti-MOG Antibody Seropositive Neuromyelitis Optica: A Rare Pediatric Case.

Authors:  Gonca Koç; Nurettin Bayram; Ahmet Sami Güven; Doğan Bahadır İnan; Ali Kaya
Journal:  Noro Psikiyatr Ars       Date:  2019-02-05       Impact factor: 1.339

Review 10.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.